IL36G and neoplasm: To delineate their contribution to tumor control in vivo, we utilized anti-Ly6G or anti-Gr1 mAbs to deplete neutrophils alone, or both neutrophils and monocytes, respectively in Rag-KO animals bearing IL-36γ–expressing or control MC38 tumors (Supplemental Figure 4, C and D).